On the team at a scalp/skin AI startup. Wanted to share a counterintuitive call: we classify our own tool as high-risk under the EU AI Act and say so openly, rather than engineering the description to dodge that tier.
The instinct in a lot of health-AI is to frame the product as "wellness" or "educational" to stay out of medical-device scope. Sometimes that's legitimate; often it's regulatory arbitrage that catches up with you.
Our reasoning: in a medical-adjacent market, the compliance posture is the trust signal. CE marking, transparency about what the model can't do, explicit "this isn't a diagnosis" framing — that's not overhead, it's the moat. Customers (clinics, especially) read re